Hey everybody, Dave Bartosiak with Trending Stocks for Zacks.com. Roku is nearing a distribution deal with AT&T for HBO Max. Not to be confused with Boeing’s Death Trap that is the 737 MAX nor HBO GO nor HBO Now. It’s HBO’s standalone streaming service that will set you back $15 a month. Rumors about a
The 2010s bull market was the first one to ever celebrate its 10-year anniversary, and while the COVID-19 pandemic caused its fair share of challenges, the market quickly roared back to all-time highs. It’s impossible to know how long the S&P 500 will continue to march higher, but for investors who are nearing retirement, it
It’s definitely fair to say that New York-based Lemonade (NYSE:LMND) is on a mission. If you’re on board with the idea of using AI technology to disrupt insurance as we know it, then a position in LMND stock might be right for you. Source: Stephanie L Sanchez / Shutterstock.com Just to give you a refresher, Lemonade
William Shatner Anjali Sundaram | CNBC Science fiction will soon become reality, as William Shatner is scheduled to launch on the next crewed spaceflight of Jeff Bezos’ Blue Origin. Blue Origin plans to fly the Canadian actor, who famously played Captain Kirk in the original Star Trek television series, as one of the passengers on
Take a look at some of the biggest movers in the premarket: Tesla (TSLA) – Tesla shares rose 3% in the premarket after the company announced it delivered 241,300 vehicles during the third quarter, its most ever for a quarter and a 73% increase over the same quarter a year ago. Moderna (MRNA), Novavax (NVAX)
Tesla (NASDAQ:TSLA) is still not the world’s most valuable carmaker. Toyota Motor (NYSE:TM) is, for now. Its resistance to the EV revolution makes TM stock a problem in the long term. Source: josefkubes / Shutterstock.com With a market cap of $1.28 trillion, on what should be sales of $270 billion in 2021, Toyota dwarfs every competitor. Toyota
Often attributed (though no one knows for sure) to Joseph Kennedy, a nevertheless oft-cited quote states, “If shoeshine boys are giving stock tips, then it’s time to get out of the market.” I don’t want to speak out of turn, but I’m having similar reservations about Sphere 3D (NASDAQ:ANY). Suddenly, it seems everyone is eyeballing
ViacomCBS (NASDAQ:VIAC) has been a costly disappointment for some investors in 2021. Enthusiasm over the company’s newly-announced streaming plans paired with Reddit-fueled retail investors drove VIAC stock past $100 three weeks into March. That was a 174% gain in under four months. Source: Jer123 / Shutterstock.com A catastrophic crash then saw shares lose half their
Engine No. 1, the firm that rose to prominence after waging a successful campaign against Exxon, on Monday announced an investment in General Motors. This time, the upstart activist’s stake signals support for the automaker as it transitions to electric vehicles. Engine No. 1 pointed to the similarities between Exxon and GM, noting that each
In this article FB DD UNP F Facebook’s logo displayed on a phone screen. Jakub Porzycki | NurPhoto via Getty Images Check out the companies making headlines in midday trading. Facebook — Facebook shares fell 5.5% after a company whistleblower unveiled her identify and accused the social media giant of a “betrayal of democracy.” The
A bit of positive news included in Carnival’s (NYSE:CCL) second-quarter results lifted CCL stock in late September. But even as the world appears on track to get “back to normal,” you may not want to buy Carnival’s shares at its present levels. There’s a good chance that the cruise line operator’s results will fully bounce
Recently, Novavax (NASDAQ:NVAX) fell fast. Closing at $207.31 per share on Sept. 30, the vaccine play opened at around $190 on Oct. 1. After that, NVAX stock quickly went into free fall, dropping as low as $154 per share. Source: Ascannio/Shutterstock.com The reason? Breaking news of Merck’s (NYSE:MRK) antiviral Covid-19 pill. Interim results suggest it
On today’s show, Preston and Stig talk about the current market conditions and how they are positioning their portfolio. In the second half of the show, they talk about previous mastermind picks and how they have performed when compared to the S&P500. IN THIS EPISODE, YOU’LL LEARN: – How Preston and Stig’s previous stock picks
I’ve got a question for you. How many shares are you trading currently on per trade basis? How do you decide that? Well, there’s a lot of people out there that wonder exactly this “How many shares should they trade” Should I trade 2 percent of my account size? Or just always trade 100 shares
In the Century of Biology, it pays to own the future of curing disease at the root.
We hear it all the time: The middle class is shrinking. Wages seem to have been stagnant for decades and American families are struggling with financial insecurity. However, what exactly is the middle class? Who is in it, and who is not? Is it shrinking? What about you? Which income class do you belong to?
Hyliion Holdings (NYSE:HYLN) has been a painful investment for many. A year ago, it shares were was trading as high as $55 a piece. Yet its been downhill ever since. I cautioned in March that a HYLN stock investment would require patience. Source: Hyliion media The stock is down nearly 50% since that call. Despite
A year ago, electric vehicles (EVs) were a promising sector for investors. But in 2021, that all changed. Sponsors of special purpose acquisition companies (SPACs) flooded the market with new EV stock investments. Some of these, like Lucid Motors (NASDAQ:LCID), have worked out pretty well. Most, however, have been terrible for investors. Unfortunately, Lordstown Motors
Have you been keeping an eye on the developments in the genetic editing space? We have. Source: Shutterstock And recently, CRISPR gene editing pioneer Feng Zhang achieved a breakthrough in CRISPR therapy cell-delivery. Instead of using the “default” Cas9 enzyme, Zhang used a sub-family of the Cas13 enzyme. One that’s just tiny enough to fit
Here’s a rare opportunity for you. A “next-generation Medicare Advantage insurer,” Clover Health (NASDAQ:CLOV) operates in a high-potential market, providing health care access to seniors and other patient demographics. Yet, CLOV stock is trading at a surprisingly low price. Source: Shutterstock Currently, this stock has landed gently at a strong support level. So, it might be